FDA Inspection
Quagen Pharma, LLCQuagen Pharma, LLC – FDA Inspection, Oct 26, 2020
Record Details
This FDA Inspection record concerns Quagen Pharma, LLC, with an inspection on October 26, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Quagen Pharma, LLC
- Inspection Date
- October 26, 2020
- Product Type
- Drugs
View Company Profile
ID · 37c76534-357b-4c19-a023-7470a89d61f6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1131910
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Quagen Pharma, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2026 | Not classified | New Jersey District Office | |
| May 9, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 15, 2019 | Not classified | New Jersey District Office |
Other documents for Quagen Pharma, LLC
- FDA Inspection 1306964 - 2026-04-17
- FDA Inspection 1207909 - 2023-05-09
- FDA Inspection 1082687 - 2019-03-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.